Comparative binding studies of bacosine with human serum albumin and α-1-acid glycoprotein biophysical evaluation and computational approach.
Autor: | Yeggoni DP; Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad 500046, India., Rachamallu A; National Institute of Animal Biotechnology, Q City Road, Gachibowli, Hyderabad, Telangana 500032, India., Subramanyam R; Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad 500046, India. Electronic address: srgsl@uohyd.ernet.in. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2022 Feb 05; Vol. 209, pp. 114478. Date of Electronic Publication: 2021 Nov 24. |
DOI: | 10.1016/j.jpba.2021.114478 |
Abstrakt: | Bacosine (BAC) is a natural product isolated from a herb and used in the Ayurvedic system of medicine. It is reported to have a wide array of biological activities, which has generated interest in its therapeutic potential. To better understand how BAC may operate as a potential anti-cancer therapeutic, we examined its anti-cancer properties in the human breast cancer cell line, MCF-7. In order to get an idea of how it may behave in vivo, we also evaluated its interaction with human serum albumin (HSA) and α-1-acid glycoprotein (AGP) using fluorescence spectroscopy and in silico molecular modelling. Based on our in vitro studies, we found that BAC inhibited MCF-7 cell growth in a dose-dependent manner with an IC Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2021 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |